204 related articles for article (PubMed ID: 3277379)
1. A tumor-associated antigen in carcinoma of the pancreas defined by monoclonal antibody B72.3.
Lyubsky S; Madariaga J; Lozowski M; Mishriki Y; Schuss A; Chao S; Lundy J
Am J Clin Pathol; 1988 Feb; 89(2):160-7. PubMed ID: 3277379
[TBL] [Abstract][Full Text] [Related]
2. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture.
Johnston WW
Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic characterization of lung cancers in fine needle aspiration biopsies using monoclonal antibody B72.3.
Johnston WW; Szpak CA; Thor A; Schlom J
Cancer Res; 1986 Dec; 46(12 Pt 1):6462-70. PubMed ID: 3022920
[TBL] [Abstract][Full Text] [Related]
4. Applications of immunocytochemistry to clinical cytology.
Johnston WW; Szpak CA; Thor A; Simpson JF; Schlom J
Cancer Invest; 1987; 5(6):593-611. PubMed ID: 3327572
[TBL] [Abstract][Full Text] [Related]
5. Lack of specificity of monoclonal antibody B72.3 in distinguishing chronic pancreatitis from pancreatic adenocarcinoma.
Loy TS; Springer D; Chapman RK; Diaz-Arias AA; Bulatao IS; Bickel JT
Am J Clin Pathol; 1991 Dec; 96(6):684-8. PubMed ID: 1720919
[TBL] [Abstract][Full Text] [Related]
6. Expression of Tn, sialosyl Tn, and T antigens in human pancreas.
Itzkowitz S; Kjeldsen T; Friera A; Hakomori S; Yang US; Kim YS
Gastroenterology; 1991 Jun; 100(6):1691-700. PubMed ID: 1850375
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies against human pancreatic adenocarcinoma: distribution of DU-PAN-2 antigen on glandular epithelia and adenocarcinomas.
Borowitz MJ; Tuck FL; Sindelar WF; Fernsten PD; Metzgar RS
J Natl Cancer Inst; 1984 May; 72(5):999-1005. PubMed ID: 6371347
[TBL] [Abstract][Full Text] [Related]
8. Reactivity of B72.3 with adenocarcinomas. An immunohistochemical study of 476 cases.
Loy TS; Nashelsky MB
Cancer; 1993 Oct; 72(8):2495-8. PubMed ID: 8402466
[TBL] [Abstract][Full Text] [Related]
9. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
Molinolo A; Simpson JF; Thor A; Schlom J
Cancer Res; 1990 Feb; 50(4):1291-8. PubMed ID: 2297774
[TBL] [Abstract][Full Text] [Related]
10. Isolation and immunohistochemical characterization of a pancreatic carcinoma-associated monoclonal antibody.
Halwani F; Cheung M; Jothy S
Exp Mol Pathol; 1990 Oct; 53(2):99-111. PubMed ID: 1702063
[TBL] [Abstract][Full Text] [Related]
11. Reactivity of CO17-1A and B72.3 in benign and malignant pancreatic diseases.
Takiyama Y; Tempero MA; Takasaki H; Onda M; Tsuchiya R; Büchler M; Ness M; Colcher D; Schlom J; Pour PM
Hum Pathol; 1989 Sep; 20(9):832-8. PubMed ID: 2673979
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemistry with monoclonal antibody B72.3 as an adjunct in the cytologic diagnosis of pancreatic carcinoma.
Ness MJ; Pour PM; Tempero MA; Linder J
Mod Pathol; 1988 Jul; 1(4):279-83. PubMed ID: 2467286
[TBL] [Abstract][Full Text] [Related]
13. Tissue expression of the tumor marker CA 50 in benign and malignant pancreatic lesions. A comparison with CA 19-9.
Haglund C; Lindgren J; Roberts PJ; Nordling S
Int J Cancer; 1986 Dec; 38(6):841-6. PubMed ID: 3466871
[TBL] [Abstract][Full Text] [Related]
14. Complementation of anti-CEA and anti-TAG-72 monoclonal antibodies in reactivity to human gastric adenocarcinomas.
Ohuchi N; Simpson JF; Colcher D; Schlom J
Int J Cancer; 1987 Dec; 40(6):726-33. PubMed ID: 2447021
[TBL] [Abstract][Full Text] [Related]
15. Use of a monoclonal antibody (B72.3) as a novel immunohistochemical adjunct for the diagnosis of carcinomas in fine needle aspiration biopsy specimens.
Johnston WW; Szpak CA; Lottich SC; Thor A; Schlom J
Hum Pathol; 1986 May; 17(5):501-13. PubMed ID: 2422108
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3).
Szpak CA; Johnston WW; Roggli V; Kolbeck J; Lottich SC; Vollmer R; Thor A; Schlom J
Am J Pathol; 1986 Feb; 122(2):252-60. PubMed ID: 2418688
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal carcinoma-associated antigen defined by a murine monoclonal antibody.
Chin JK; Rong GH; Scharff JE; Sindelar WF
J Natl Cancer Inst; 1986 Sep; 77(3):599-604. PubMed ID: 3528605
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody-defined human pancreatic cancer-associated antigens.
Schmiegel WH; Kalthoff H; Arndt R; Gieseking J; Greten H; Klöppel G; Kreiker C; Ladak A; Lampe V; Ulrich S
Cancer Res; 1985 Mar; 45(3):1402-7. PubMed ID: 3882225
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic heterogeneity of a tumor-associated antigen in adenocarcinomas of the colon and their metastases as demonstrated by monoclonal antibody B72.3.
Lottich SC; Szpak CA; Johnston WW; Thor A; Schlom J
Cancer Invest; 1986; 4(5):387-95. PubMed ID: 2433005
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody to a human pancreatic carcinoma cell line recognizes gastrointestinal neoplasms.
Kahn HJ; Yeger H; Loftus R; Goldrosen MH
Am J Pathol; 1989 Mar; 134(3):641-9. PubMed ID: 2466406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
